Envestnet Asset Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
BBA
AC
CS
SC
Envestnet Asset Management's BLUE Position: Q3 2021 in Review
Envestnet Asset Management sold out of bluebird bio (BLUE) in Q3 2021, closing a stake of 502 shares — an estimated $208K sold.
Envestnet Asset Management first reported a position in BLUE in Q1 2017 and held it in 16 quarters. The position peaked at $1.47M in Q1 2019. 196 funds tracked by Wall St. Rank hold BLUE as of Q3 2021.
- Envestnet Asset Management reported no remaining bluebird bio position as of Q3 2021 after selling out during the quarter.
- Envestnet Asset Management sold 502 bluebird bio shares in Q3 2021, an estimated $208K.
- Envestnet Asset Management first reported a position in bluebird bio in Q1 2017 and held it in 16 quarters.
- Envestnet Asset Management's bluebird bio position peaked at $1.47M in Q1 2019.
- 196 funds tracked by Wall St. Rank held bluebird bio as of Q3 2021.
Based on Envestnet Asset Management's 13F filing for Q3 2021, filed 7 Oct 2021.